Hospital sao lucas

Rio de Janeiro 22061-080

0 studies enrolling now · 2 studies all time

What they study most

Acute Coronary Syndrome, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma

Studies at this site

• A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL) — Recruiting now
• A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome — Completed